By codifying the establishment of this Council, HB 1019 aims to create a structured approach to dealing with the unique challenges faced by individuals with rare diseases. The Council will gather input through public hearings and inquiries to assess the specific needs of the rare disease community in Oklahoma. It will also provide testimony regarding relevant legislation and develop policy recommendations to improve access to quality healthcare, diagnostic services, and timely treatments for rare disease patients.
Summary
House Bill 1019 establishes the Oklahoma Rare Disease Advisory Council, which will operate within the State Department of Health. The Council is mandated to provide guidance and recommendations to educate the public, legislative bodies, and state agencies on the needs of individuals affected by rare diseases in Oklahoma. This initiative is aimed at improving awareness and the quality of care for rare disease patients, caregivers, and healthcare providers in the state, ultimately striving to enhance public health outcomes for these populations.
Contention
One notable aspect of HB 1019 is its emphasis on inclusivity in terms of membership. The bill stipulates that the Council must include diverse representatives, including patients, caregivers, healthcare providers, and industry experts. This broad representation aims to ensure that a wide range of perspectives and experiences inform the Council's recommendations. However, concerns may arise regarding how effectively these voices will be integrated into policy recommendations, and whether the Council can address the pressing healthcare needs of rare disease patients in a timely and efficient manner.
Public retirement systems; Oklahoma Pension Actuarial Analysis Act; Oklahoma Law Enforcement Retirement System; definition; membership; Council on Law Enforcement Education and Training; codification; effective dates; emergency.